Selected research
Market Outlook & Growth Opportunities
Global Research Grade Plasmid DNA Manufacturing Market Outlook and Growth Opportunities 2026
Market perspective
The global Research Grade Plasmid DNA Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Research Grade Plasmid DNA Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Research Grade Plasmid DNA Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Research Grade Plasmid DNA Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Research Grade Plasmid DNA Manufacturing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Research Grade Plasmid DNA Manufacturing market include Charles River Laboratories, Creative Biogene, AmplifyBio, Catalent Biologics, PlasmidFactory, GenScript ProBio, Aldevron LLC, PackGene Biotech lnc and WuXi Advanced Therapies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Research Grade Plasmid DNA Manufacturing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Research Grade Plasmid DNA Manufacturing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Research Grade Plasmid DNA Manufacturing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Research Grade Plasmid DNA Manufacturing market.
Research Grade Plasmid DNA Manufacturing Segment by Company
Charles River Laboratories
Creative Biogene
AmplifyBio
Catalent Biologics
PlasmidFactory
GenScript ProBio
Aldevron LLC
PackGene Biotech lnc
WuXi Advanced Therapies
Polyplus
VectorBuilder
Pharmaron
AGC Biologics
Genovac
Xpress Biologics
VGXI
Cepham Life Sciences
Research Grade Plasmid DNA Manufacturing Segment by Type
Small-scale Manufacturing (<100 mg)
Pilot scale Manufacturing (<1 g)
Large-scale Manufacturing (>1 g)
Research Grade Plasmid DNA Manufacturing Segment by Application
In Vitro
Preclinical Studies
Others
Research Grade Plasmid DNA Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Research Grade Plasmid DNA Manufacturing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Research Grade Plasmid DNA Manufacturing key companies, revenue, market share, and recent developments.
3. To split the Research Grade Plasmid DNA Manufacturing breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Research Grade Plasmid DNA Manufacturing market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Research Grade Plasmid DNA Manufacturing significant trends, drivers, influence factors in global and regions.
6. To analyze Research Grade Plasmid DNA Manufacturing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Research Grade Plasmid DNA Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Research Grade Plasmid DNA Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Research Grade Plasmid DNA Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Research Grade Plasmid DNA Manufacturing industry.
Chapter 3: Detailed analysis of Research Grade Plasmid DNA Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Research Grade Plasmid DNA Manufacturing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Research Grade Plasmid DNA Manufacturing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Small-scale Manufacturing (<100 mg)
- Pilot scale Manufacturing (<1 g)
- Large-scale Manufacturing (>1 g)
Applications
- In Vitro
- Preclinical Studies
- Others
Companies covered
- Charles River Laboratories
- Creative Biogene
- AmplifyBio
- Catalent Biologics
- PlasmidFactory
- GenScript ProBio
- Aldevron LLC
- PackGene Biotech lnc
- WuXi Advanced Therapies
- Polyplus
- VectorBuilder
- Pharmaron
- AGC Biologics
- Genovac
- Xpress Biologics
- VGXI
- Cepham Life Sciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Research Grade Plasmid DNA Manufacturing Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Research Grade Plasmid DNA Manufacturing Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Research Grade Plasmid DNA Manufacturing Market Dynamics
- 2.1 Research Grade Plasmid DNA Manufacturing Industry Trends
- 2.2 Research Grade Plasmid DNA Manufacturing Industry Drivers
- 2.3 Research Grade Plasmid DNA Manufacturing Industry Opportunities and Challenges
- 2.4 Research Grade Plasmid DNA Manufacturing Industry Restraints
3 Research Grade Plasmid DNA Manufacturing Market by Company
- 3.1 Global Research Grade Plasmid DNA Manufacturing Company Revenue Ranking in 2025
- 3.2 Global Research Grade Plasmid DNA Manufacturing Revenue by Company (2021-2026)
- 3.3 Global Research Grade Plasmid DNA Manufacturing Company Ranking (2024-2026)
- 3.4 Global Research Grade Plasmid DNA Manufacturing Company Manufacturing Base and Headquarters
- 3.5 Global Research Grade Plasmid DNA Manufacturing Company Product Type and Application
- 3.6 Global Research Grade Plasmid DNA Manufacturing Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Research Grade Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Research Grade Plasmid DNA Manufacturing Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Research Grade Plasmid DNA Manufacturing Market by Type
- 4.1 Research Grade Plasmid DNA Manufacturing Type Introduction
- 4.1.1 Small-scale Manufacturing (<100 mg)
- 4.1.2 Pilot scale Manufacturing (<1 g)
- 4.1.3 Large-scale Manufacturing (>1 g)
- 4.2 Global Research Grade Plasmid DNA Manufacturing Sales Value by Type
- 4.2.1 Global Research Grade Plasmid DNA Manufacturing Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Research Grade Plasmid DNA Manufacturing Sales Value by Type (2021-2032)
- 4.2.3 Global Research Grade Plasmid DNA Manufacturing Sales Value Share by Type (2021-2032)
5 Research Grade Plasmid DNA Manufacturing Market by Application
- 5.1 Research Grade Plasmid DNA Manufacturing Application Introduction
- 5.1.1 In Vitro
- 5.1.2 Preclinical Studies
- 5.1.3 Others
- 5.2 Global Research Grade Plasmid DNA Manufacturing Sales Value by Application
- 5.2.1 Global Research Grade Plasmid DNA Manufacturing Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Research Grade Plasmid DNA Manufacturing Sales Value by Application (2021-2032)
- 5.2.3 Global Research Grade Plasmid DNA Manufacturing Sales Value Share by Application (2021-2032)
6 Research Grade Plasmid DNA Manufacturing Regional Value Analysis
- 6.1 Global Research Grade Plasmid DNA Manufacturing Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Research Grade Plasmid DNA Manufacturing Sales Value by Region (2021-2032)
- 6.2.1 Global Research Grade Plasmid DNA Manufacturing Sales Value by Region: 2021-2026
- 6.2.2 Global Research Grade Plasmid DNA Manufacturing Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Research Grade Plasmid DNA Manufacturing Sales Value (2021-2032)
- 6.3.2 North America Research Grade Plasmid DNA Manufacturing Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Research Grade Plasmid DNA Manufacturing Sales Value (2021-2032)
- 6.4.2 Europe Research Grade Plasmid DNA Manufacturing Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Research Grade Plasmid DNA Manufacturing Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Research Grade Plasmid DNA Manufacturing Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Research Grade Plasmid DNA Manufacturing Sales Value (2021-2032)
- 6.6.2 South America Research Grade Plasmid DNA Manufacturing Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Research Grade Plasmid DNA Manufacturing Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Research Grade Plasmid DNA Manufacturing Sales Value Share by Country, 2025 VS 2032
7 Research Grade Plasmid DNA Manufacturing Country-level Value Analysis
- 7.1 Global Research Grade Plasmid DNA Manufacturing Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Research Grade Plasmid DNA Manufacturing Sales Value by Country (2021-2032)
- 7.2.1 Global Research Grade Plasmid DNA Manufacturing Sales Value by Country (2021-2026)
- 7.2.2 Global Research Grade Plasmid DNA Manufacturing Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.7.2 France Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.14.2 China Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.17.2 India Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Research Grade Plasmid DNA Manufacturing Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Research Grade Plasmid DNA Manufacturing Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Research Grade Plasmid DNA Manufacturing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Charles River Laboratories
- 8.1.1 Charles River Laboratories Company Information
- 8.1.2 Charles River Laboratories Business Overview
- 8.1.3 Charles River Laboratories Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.1.4 Charles River Laboratories Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.1.5 Charles River Laboratories Recent Developments
- 8.2 Creative Biogene
- 8.2.1 Creative Biogene Company Information
- 8.2.2 Creative Biogene Business Overview
- 8.2.3 Creative Biogene Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.2.4 Creative Biogene Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.2.5 Creative Biogene Recent Developments
- 8.3 AmplifyBio
- 8.3.1 AmplifyBio Company Information
- 8.3.2 AmplifyBio Business Overview
- 8.3.3 AmplifyBio Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.3.4 AmplifyBio Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.3.5 AmplifyBio Recent Developments
- 8.4 Catalent Biologics
- 8.4.1 Catalent Biologics Company Information
- 8.4.2 Catalent Biologics Business Overview
- 8.4.3 Catalent Biologics Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.4.4 Catalent Biologics Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.4.5 Catalent Biologics Recent Developments
- 8.5 PlasmidFactory
- 8.5.1 PlasmidFactory Company Information
- 8.5.2 PlasmidFactory Business Overview
- 8.5.3 PlasmidFactory Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.5.4 PlasmidFactory Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.5.5 PlasmidFactory Recent Developments
- 8.6 GenScript ProBio
- 8.6.1 GenScript ProBio Company Information
- 8.6.2 GenScript ProBio Business Overview
- 8.6.3 GenScript ProBio Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.6.4 GenScript ProBio Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.6.5 GenScript ProBio Recent Developments
- 8.7 Aldevron LLC
- 8.7.1 Aldevron LLC Company Information
- 8.7.2 Aldevron LLC Business Overview
- 8.7.3 Aldevron LLC Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.7.4 Aldevron LLC Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.7.5 Aldevron LLC Recent Developments
- 8.8 PackGene Biotech lnc
- 8.8.1 PackGene Biotech lnc Company Information
- 8.8.2 PackGene Biotech lnc Business Overview
- 8.8.3 PackGene Biotech lnc Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.8.4 PackGene Biotech lnc Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.8.5 PackGene Biotech lnc Recent Developments
- 8.9 WuXi Advanced Therapies
- 8.9.1 WuXi Advanced Therapies Company Information
- 8.9.2 WuXi Advanced Therapies Business Overview
- 8.9.3 WuXi Advanced Therapies Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.9.4 WuXi Advanced Therapies Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.9.5 WuXi Advanced Therapies Recent Developments
- 8.10 Polyplus
- 8.10.1 Polyplus Company Information
- 8.10.2 Polyplus Business Overview
- 8.10.3 Polyplus Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.10.4 Polyplus Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.10.5 Polyplus Recent Developments
- 8.11 VectorBuilder
- 8.11.1 VectorBuilder Company Information
- 8.11.2 VectorBuilder Business Overview
- 8.11.3 VectorBuilder Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.11.4 VectorBuilder Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.11.5 VectorBuilder Recent Developments
- 8.12 Pharmaron
- 8.12.1 Pharmaron Company Information
- 8.12.2 Pharmaron Business Overview
- 8.12.3 Pharmaron Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.12.4 Pharmaron Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.12.5 Pharmaron Recent Developments
- 8.13 AGC Biologics
- 8.13.1 AGC Biologics Company Information
- 8.13.2 AGC Biologics Business Overview
- 8.13.3 AGC Biologics Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.13.4 AGC Biologics Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.13.5 AGC Biologics Recent Developments
- 8.14 Genovac
- 8.14.1 Genovac Company Information
- 8.14.2 Genovac Business Overview
- 8.14.3 Genovac Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.14.4 Genovac Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.14.5 Genovac Recent Developments
- 8.15 Xpress Biologics
- 8.15.1 Xpress Biologics Company Information
- 8.15.2 Xpress Biologics Business Overview
- 8.15.3 Xpress Biologics Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.15.4 Xpress Biologics Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.15.5 Xpress Biologics Recent Developments
- 8.16 VGXI
- 8.16.1 VGXI Company Information
- 8.16.2 VGXI Business Overview
- 8.16.3 VGXI Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.16.4 VGXI Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.16.5 VGXI Recent Developments
- 8.17 Cepham Life Sciences
- 8.17.1 Cepham Life Sciences Company Information
- 8.17.2 Cepham Life Sciences Business Overview
- 8.17.3 Cepham Life Sciences Research Grade Plasmid DNA Manufacturing Revenue and Gross Margin (2021-2026)
- 8.17.4 Cepham Life Sciences Research Grade Plasmid DNA Manufacturing Product Portfolio
- 8.17.5 Cepham Life Sciences Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst